Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Anticancer Research|January 30, 2008
Diabetes and oral oncogenesisEleftherios Vairaktaris, Sofia Spyridonidou, Lambros Goutzanis, et al.
In Vivo (Athens, Greece)|November 21, 2007
Expression of cell cycle regulator p16 is not affected by diabetes during oral oncogenesisEleftherios Vairaktaris, Lambros Goutzanis, Emeka Nkenke, et al.
In Vivo (Athens, Greece)|November 21, 2007
Evaluation of apoptosis in nasal and buccal cells of septic patientsStavros Vassiliou, Christos Yapijakis, Spyridoula Derka, et al.
Journal of Cancer Research and Clinical Oncology|August 21, 2007
Enhancement of erbB2 and erbB3 expression during oral oncogenesis in diabetic ratsEleftherios Vairaktaris, Lambros Goutzanis, Stavros Vassiliou, et al.
Anticancer Research|June 29, 2007
Diabetes alters expression of p53 and c-myc in different stages of oral oncogenesisEleftherios Vairaktaris, Giorgos Kalokerinos, Lambros Goutzanis, et al.
In Vivo (Athens, Greece)|August 22, 2007
Diabetes does not influence oral oncogenesis through fibroblast growth factor receptorsEleftherios Vairaktaris, Lambros Goutzanis, Emeka Nkenke, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|November 21, 2007
Increased risk of oral cancer in diabetic animals is not associated with c-jun activation pathwayEleftherios Vairaktaris, Lambros Goutzanis, Georgios Kalokerinos, et al.
In Vivo (Athens, Greece)|August 22, 2007
Diabetes increases both N-ras and ets-1 expression during rat oral oncogenesis resulting in enhanced cell proliferation and metastatic potentialEleftherios Vairaktaris, Lambros Goutzanis, Giorgos Kalokerinos, et al.
Pageof 1